-
Societal and Economic Impact of Targeted Therapy for Breast Cancer in Bulgaria
Sep 9, 2025, 16:22 PM -
A Nutrient-Dense Formula in Undernourished Children in Indonesia: An Effective Cost-Saving Strategy
Sep 9, 2025, 16:22 PM -
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Early FGFR3 Testing in Metastatic Urothelial Carcinoma: A Finnish Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Epidemiological Insights in Merkel Cell Carcinoma Across Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Utilization of Real-World Evidence (RWE) in AMNOG Dossiers Following the 2024 GBA Revision of Module 3 Requirements
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Transcatheter Valve Replacement Using Valves With RESILIA Tissue for the Treatment of Aortic Stenosis in South Korea
Sep 9, 2025, 16:22 PM -
Do The Guardrails Have Any Effect at All? An Analysis of the Impact of the 2022 FINSTG Guardrails on the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder
Sep 9, 2025, 16:22 PM -
Infective Endocarditis Following FRANCE-TAVI Insights
Sep 9, 2025, 16:22 PM -
Sex Differences in Autoimmune Multimorbidity Across 11 Autoimmune Disorders in the Real-World Setting in Germany
Sep 9, 2025, 16:22 PM -
Balancing Cost-Effectiveness With Societal Values: A Representative Survey of Norwegian Attitudes Toward Healthcare Resource Allocation
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the BCIS Conveyance Algorithm for Out-of-Hospital Cardiac Arrest Patients
Sep 9, 2025, 16:22 PM -
Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions
Sep 9, 2025, 16:22 PM -
Conceptualizing an Economic Model Structure for Parkinson's Disease
Sep 9, 2025, 16:22 PM -
Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study
Sep 9, 2025, 16:22 PM -
Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program
Sep 9, 2025, 16:22 PM -
Rising Polypharmacy Trends and Associated Factors in Chinese Adults With Diabetes: A Population-Based Cohort Study
Sep 9, 2025, 16:22 PM -
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Qualitative Analysis of Results From a Delphi Study to Formalize a Treatment Protocol for Children With Early Diagnosed Duchenne Muscular Disease (DMD) Using Giles®, an Artificial Intelligence Agent for Healthcare Research
Sep 9, 2025, 16:22 PM
